2025-04-012026-03-312026-03-31false15901484DR SAGAR MASANI LIMITED2026-08-26falseiso4217:GBPxbrli:pure159014842025-03-31159014842026-03-31159014842025-04-012026-03-31159014842024-08-15159014842025-03-31159014842024-08-162025-03-3115901484bus:SmallEntities2025-04-012026-03-3115901484bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3115901484bus:FullAccounts2025-04-012026-03-3115901484bus:PrivateLimitedCompanyLtd2025-04-012026-03-3115901484core:WithinOneYear2026-03-3115901484core:AfterOneYear2026-03-3115901484core:WithinOneYear2025-03-3115901484core:AfterOneYear2025-03-3115901484core:ShareCapital2026-03-3115901484core:SharePremium2026-03-3115901484core:RevaluationReserve2026-03-3115901484core:OtherReservesSubtotal2026-03-3115901484core:RetainedEarningsAccumulatedLosses2026-03-3115901484core:ShareCapital2025-03-3115901484core:SharePremium2025-03-3115901484core:RevaluationReserve2025-03-3115901484core:OtherReservesSubtotal2025-03-3115901484core:RetainedEarningsAccumulatedLosses2025-03-3115901484core:LandBuildings2026-03-3115901484core:PlantMachinery2026-03-3115901484core:Vehicles2026-03-3115901484core:FurnitureFittings2026-03-3115901484core:OfficeEquipment2026-03-3115901484core:NetGoodwill2026-03-3115901484core:IntangibleAssetsOtherThanGoodwill2026-03-3115901484core:ListedExchangeTraded2026-03-3115901484core:UnlistedNon-exchangeTraded2026-03-3115901484core:LandBuildings2025-03-3115901484core:PlantMachinery2025-03-3115901484core:Vehicles2025-03-3115901484core:FurnitureFittings2025-03-3115901484core:OfficeEquipment2025-03-3115901484core:NetGoodwill2025-03-3115901484core:IntangibleAssetsOtherThanGoodwill2025-03-3115901484core:ListedExchangeTraded2025-03-3115901484core:UnlistedNon-exchangeTraded2025-03-3115901484core:LandBuildings2025-04-012026-03-3115901484core:PlantMachinery2025-04-012026-03-3115901484core:Vehicles2025-04-012026-03-3115901484core:FurnitureFittings2025-04-012026-03-3115901484core:OfficeEquipment2025-04-012026-03-3115901484core:NetGoodwill2025-04-012026-03-3115901484core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3115901484core:ListedExchangeTraded2025-04-012026-03-3115901484core:UnlistedNon-exchangeTraded2025-04-012026-03-3115901484core:MoreThanFiveYears2025-04-012026-03-3115901484core:Non-currentFinancialInstruments2026-03-3115901484core:Non-currentFinancialInstruments2025-03-3115901484dpl:CostSales2025-04-012026-03-3115901484dpl:DistributionCosts2025-04-012026-03-3115901484core:LandBuildings2025-04-012026-03-3115901484core:PlantMachinery2025-04-012026-03-3115901484core:Vehicles2025-04-012026-03-3115901484core:FurnitureFittings2025-04-012026-03-3115901484core:OfficeEquipment2025-04-012026-03-3115901484dpl:AdministrativeExpenses2025-04-012026-03-3115901484core:NetGoodwill2025-04-012026-03-3115901484core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3115901484dpl:GroupUndertakings2025-04-012026-03-3115901484dpl:ParticipatingInterests2025-04-012026-03-3115901484dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3115901484core:ListedExchangeTraded2025-04-012026-03-3115901484dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3115901484core:UnlistedNon-exchangeTraded2025-04-012026-03-3115901484dpl:CostSales2024-08-162025-03-3115901484dpl:DistributionCosts2024-08-162025-03-3115901484core:LandBuildings2024-08-162025-03-3115901484core:PlantMachinery2024-08-162025-03-3115901484core:Vehicles2024-08-162025-03-3115901484core:FurnitureFittings2024-08-162025-03-3115901484core:OfficeEquipment2024-08-162025-03-3115901484dpl:AdministrativeExpenses2024-08-162025-03-3115901484core:NetGoodwill2024-08-162025-03-3115901484core:IntangibleAssetsOtherThanGoodwill2024-08-162025-03-3115901484dpl:GroupUndertakings2024-08-162025-03-3115901484dpl:ParticipatingInterests2024-08-162025-03-3115901484dpl:GroupUndertakingscore:ListedExchangeTraded2024-08-162025-03-3115901484core:ListedExchangeTraded2024-08-162025-03-3115901484dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-08-162025-03-3115901484core:UnlistedNon-exchangeTraded2024-08-162025-03-3115901484core:NetGoodwill2026-03-3115901484core:IntangibleAssetsOtherThanGoodwill2026-03-3115901484core:LandBuildings2026-03-3115901484core:PlantMachinery2026-03-3115901484core:Vehicles2026-03-3115901484core:FurnitureFittings2026-03-3115901484core:OfficeEquipment2026-03-3115901484core:AfterOneYear2026-03-3115901484core:WithinOneYear2026-03-3115901484core:ListedExchangeTraded2026-03-3115901484core:UnlistedNon-exchangeTraded2026-03-3115901484core:ShareCapital2026-03-3115901484core:SharePremium2026-03-3115901484core:RevaluationReserve2026-03-3115901484core:OtherReservesSubtotal2026-03-3115901484core:RetainedEarningsAccumulatedLosses2026-03-3115901484core:NetGoodwill2025-03-3115901484core:IntangibleAssetsOtherThanGoodwill2025-03-3115901484core:LandBuildings2025-03-3115901484core:PlantMachinery2025-03-3115901484core:Vehicles2025-03-3115901484core:FurnitureFittings2025-03-3115901484core:OfficeEquipment2025-03-3115901484core:AfterOneYear2025-03-3115901484core:WithinOneYear2025-03-3115901484core:ListedExchangeTraded2025-03-3115901484core:UnlistedNon-exchangeTraded2025-03-3115901484core:ShareCapital2025-03-3115901484core:SharePremium2025-03-3115901484core:RevaluationReserve2025-03-3115901484core:OtherReservesSubtotal2025-03-3115901484core:RetainedEarningsAccumulatedLosses2025-03-3115901484core:NetGoodwill2024-08-1515901484core:IntangibleAssetsOtherThanGoodwill2024-08-1515901484core:LandBuildings2024-08-1515901484core:PlantMachinery2024-08-1515901484core:Vehicles2024-08-1515901484core:FurnitureFittings2024-08-1515901484core:OfficeEquipment2024-08-1515901484core:AfterOneYear2024-08-1515901484core:WithinOneYear2024-08-1515901484core:ListedExchangeTraded2024-08-1515901484core:UnlistedNon-exchangeTraded2024-08-1515901484core:ShareCapital2024-08-1515901484core:SharePremium2024-08-1515901484core:RevaluationReserve2024-08-1515901484core:OtherReservesSubtotal2024-08-1515901484core:RetainedEarningsAccumulatedLosses2024-08-1515901484core:AfterOneYear2025-04-012026-03-3115901484core:WithinOneYear2025-04-012026-03-3115901484core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3115901484core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3115901484core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3115901484core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3115901484core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3115901484core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3115901484core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3115901484core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3115901484core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3115901484core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3115901484core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3115901484core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3115901484core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3115901484core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3115901484core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3115901484core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3115901484core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3115901484core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3115901484core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3115901484core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3115901484core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3115901484core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3115901484core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3115901484core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3115901484core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3115901484core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3115901484core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3115901484bus:Director12025-04-012026-03-31

DR SAGAR MASANI LIMITED

Registered Number
15901484
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

DR SAGAR MASANI LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Director

Dr Sagar Masani

Registered Address

Fulford Lodge
1 Heslington Lane
York
YO10 4HN

Registered Number

15901484 (England and Wales)
DR SAGAR MASANI LIMITED
Statement of Financial Position
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets312,88012,813
12,88012,813
Current assets
Debtors414,89114,136
Cash at bank and on hand160,83485,878
175,725100,014
Creditors amounts falling due within one year5(45,589)(31,976)
Net current assets (liabilities)130,13668,038
Total assets less current liabilities143,01680,851
Provisions for liabilities6(3,220)(3,203)
Net assets139,79677,648
Capital and reserves
Called up share capital100100
Profit and loss account139,69677,548
Shareholders' funds139,79677,648
The financial statements were approved and authorised for issue by the Director on 26 August 2026, and are signed on its behalf by:
Dr Sagar Masani
Director
Registered Company No. 15901484
DR SAGAR MASANI LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)
Plant and machinery20
Office Equipment20
2.Average number of employees

20262025
Average number of employees during the year11
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 April 2516,016-16,016
Additions3,3691273,496
Disposals(235)-(235)
At 31 March 2619,15012719,277
Depreciation and impairment
At 01 April 253,203-3,203
Charge for year3,199423,241
On disposals(47)-(47)
At 31 March 266,355426,397
Net book value
At 31 March 2612,7958512,880
At 31 March 2512,813-12,813
4.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables14,33314,136
Prepayments and accrued income558-
Total14,89114,136
5.Creditors: amounts due within one year

2026

2025

££
Bank borrowings and overdrafts13,5609,846
Taxation and social security31,17921,596
Accrued liabilities and deferred income850534
Total45,58931,976
6.Provisions for liabilities

2026

2025

££
Net deferred tax liability (asset)3,2203,203
Total3,2203,203
7.Related party transactions
During the year, the directors made available a loan to the company. The balance of this loan as at 31 March 2026 was £13,560.29 (2025: £9,846.45). Interest has been charged on the balance on a monthly basis, at the UK market rate.